Anthony Morlandt
Oral & Maxillofacial Surgery Birmingham, AL Doctor of Dentistry
NPI 1649473638 CMS profile 165224
1919 7Th Ave S, Rm 419, Birmingham, AL 35233
General payments
$18,545
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$19,863
Through program year 2025, Anthony Morlandt of Birmingham, AL is reported in the CMS Open Payments database as having received $18,545 across 61 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $19,863 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 95th percentile of Oral & Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $752 | 11 | |
| 2024 | General | $250 | 4 | |
| 2023 | General | $489 | 5 | |
| 2022 | General | $573 | 8 | |
| 2021 | General | $1,832 | 10 | |
| 2020 | General | $2,545 | 2 | |
| 2019 | General | $12,104 | 21 |
Beside peers
- Anthony Morlandt
- Oral & Maxillofacial Surgery median
- Middle half of Oral & Maxillofacial Surgery
- National median
In program year 2025, general payments to Anthony Morlandt were reported at $752. Among 792 Oral & Maxillofacial Surgery profiles paid that year, the median was $184 and the middle half received between $61 and $541.
Show as a table
| Year | Anthony Morlandt | Oral & Maxillofacial Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $12,104 | $178 | $56–$584 | $163 |
| 2020 | $2,545 | $106 | $38–$316 | $114 |
| 2021 | $1,832 | $165 | $57–$511 | $132 |
| 2022 | $573 | $173 | $63–$494 | $149 |
| 2023 | $489 | $184 | $62–$521 | $160 |
| 2024 | $250 | $197 | $65–$603 | $164 |
| 2025 | $752 | $184 | $61–$541 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 99 billing codesPaid by Medicare
$163,324
Medicare patients
142
Services billed
775
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 53% | |
| Diabetes | 39% | |
| Ischemic heart disease | 36% | |
| Chronic kidney disease | 25% | |
| Depression | 25% | |
| COPD | 24% | |
| Atrial fibrillation | 18% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
61 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Oral & Maxillofacial Surgery in Alabama
Patrick Louis
Oral & Maxillofacial Surgery · Birmingham, AL
Michael Babston
Oral & Maxillofacial Surgery · Mobile, AL
Sami Nizam
Oral & Maxillofacial Surgery · Montgomery, AL
John Carlson
Oral & Maxillofacial Surgery · Tuscaloosa, AL
James Link
Oral & Maxillofacial Surgery · Tuscaloosa, AL
John Farnham
Oral & Maxillofacial Surgery · Tuscaloosa, AL
Related records
Oral & Maxillofacial Surgery in Alabama
Practitioners in the same specialty and state, ranked by reported value.
All Oral & Maxillofacial Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Alabama
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.